(Total Views: 347)
Posted On: 02/06/2020 10:56:12 AM
Post# of 145900
It was in the CC PR:
“ Status of filing the Biologics License Application (BLA) for leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients.”
“ Status of filing the Biologics License Application (BLA) for leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients.”
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)